Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOSL1
|
ENSG00000175592.4 | FOS like 1, AP-1 transcription factor subunit |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOSL1 | hg19_v2_chr11_-_65667884_65667895 | 0.56 | 8.8e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_394196 | 9.28 |
ENST00000331563.2
ENST00000531857.1 |
PKP3
|
plakophilin 3 |
chr19_-_56056888 | 7.66 |
ENST00000592464.1
ENST00000420723.3 |
SBK3
|
SH3 domain binding kinase family, member 3 |
chr17_-_39769005 | 7.06 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr1_-_95007193 | 6.32 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr7_+_73245193 | 6.12 |
ENST00000340958.2
|
CLDN4
|
claudin 4 |
chr2_+_27505260 | 5.91 |
ENST00000380075.2
ENST00000296098.4 |
TRIM54
|
tripartite motif containing 54 |
chr10_-_76868931 | 5.38 |
ENST00000372700.3
ENST00000473072.2 ENST00000491677.2 ENST00000607131.1 ENST00000372702.3 |
DUSP13
|
dual specificity phosphatase 13 |
chr20_-_62129163 | 5.37 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr2_+_170366203 | 5.34 |
ENST00000284669.1
|
KLHL41
|
kelch-like family member 41 |
chr17_+_4853442 | 4.98 |
ENST00000522301.1
|
ENO3
|
enolase 3 (beta, muscle) |
chr10_-_21463116 | 4.76 |
ENST00000417816.2
|
NEBL
|
nebulette |
chr4_+_120056939 | 4.74 |
ENST00000307128.5
|
MYOZ2
|
myozenin 2 |
chr16_-_14109841 | 4.69 |
ENST00000576797.1
ENST00000575424.1 |
CTD-2135D7.5
|
CTD-2135D7.5 |
chr10_-_76868866 | 4.68 |
ENST00000607487.1
|
DUSP13
|
dual specificity phosphatase 13 |
chr3_-_39234074 | 4.49 |
ENST00000340369.3
ENST00000421646.1 ENST00000396251.1 |
XIRP1
|
xin actin-binding repeat containing 1 |
chr8_-_82395461 | 4.32 |
ENST00000256104.4
|
FABP4
|
fatty acid binding protein 4, adipocyte |
chr10_+_24755416 | 4.21 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
chr9_+_34992846 | 4.19 |
ENST00000443266.1
|
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr11_-_102714534 | 4.19 |
ENST00000299855.5
|
MMP3
|
matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
chr16_-_2908155 | 4.12 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
chrX_-_33229429 | 4.09 |
ENST00000420596.1
ENST00000448370.1 |
DMD
|
dystrophin |
chr5_+_150020240 | 4.06 |
ENST00000519664.1
|
SYNPO
|
synaptopodin |
chr11_+_394145 | 4.04 |
ENST00000528036.1
|
PKP3
|
plakophilin 3 |
chr12_-_91573249 | 4.04 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
chr19_+_50706866 | 4.00 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
chr10_+_88428370 | 3.93 |
ENST00000372066.3
ENST00000263066.6 ENST00000372056.4 ENST00000310944.6 ENST00000361373.4 ENST00000542786.1 |
LDB3
|
LIM domain binding 3 |
chr12_+_13349711 | 3.91 |
ENST00000538364.1
ENST00000396301.3 |
EMP1
|
epithelial membrane protein 1 |
chr12_+_13349650 | 3.89 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1
|
epithelial membrane protein 1 |
chr11_-_111783919 | 3.81 |
ENST00000531198.1
ENST00000533879.1 |
CRYAB
|
crystallin, alpha B |
chr10_-_75423560 | 3.80 |
ENST00000606523.1
|
SYNPO2L
|
synaptopodin 2-like |
chr15_+_51633826 | 3.76 |
ENST00000335449.6
|
GLDN
|
gliomedin |
chr11_-_47207390 | 3.75 |
ENST00000539589.1
ENST00000528462.1 |
PACSIN3
|
protein kinase C and casein kinase substrate in neurons 3 |
chr11_-_111784005 | 3.69 |
ENST00000527899.1
|
CRYAB
|
crystallin, alpha B |
chr7_+_30960915 | 3.61 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr16_-_69760409 | 3.59 |
ENST00000561500.1
ENST00000439109.2 ENST00000564043.1 ENST00000379046.2 ENST00000379047.3 |
NQO1
|
NAD(P)H dehydrogenase, quinone 1 |
chr12_-_91573132 | 3.56 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
chr19_-_46285646 | 3.56 |
ENST00000458663.2
|
DMPK
|
dystrophia myotonica-protein kinase |
chr17_-_39743139 | 3.55 |
ENST00000167586.6
|
KRT14
|
keratin 14 |
chr12_-_56101647 | 3.39 |
ENST00000347027.6
ENST00000257879.6 ENST00000257880.7 ENST00000394230.2 ENST00000394229.2 |
ITGA7
|
integrin, alpha 7 |
chr19_-_36019123 | 3.39 |
ENST00000588674.1
ENST00000452271.2 ENST00000518157.1 |
SBSN
|
suprabasin |
chr10_+_88428206 | 3.33 |
ENST00000429277.2
ENST00000458213.2 ENST00000352360.5 |
LDB3
|
LIM domain binding 3 |
chr11_-_10920714 | 3.29 |
ENST00000533941.1
|
CTD-2003C8.2
|
CTD-2003C8.2 |
chr11_-_111794446 | 3.25 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
chr3_-_149293990 | 3.16 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
chr12_-_91573316 | 3.14 |
ENST00000393155.1
|
DCN
|
decorin |
chr19_+_38794797 | 3.13 |
ENST00000301246.5
ENST00000588605.1 |
C19orf33
|
chromosome 19 open reading frame 33 |
chr5_-_41794663 | 3.09 |
ENST00000510634.1
|
OXCT1
|
3-oxoacid CoA transferase 1 |
chr17_-_39781054 | 3.07 |
ENST00000463128.1
|
KRT17
|
keratin 17 |
chr11_-_47206965 | 3.04 |
ENST00000525725.1
|
PACSIN3
|
protein kinase C and casein kinase substrate in neurons 3 |
chr10_+_123872483 | 3.03 |
ENST00000369001.1
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
chr17_-_39780634 | 3.02 |
ENST00000577817.2
|
KRT17
|
keratin 17 |
chr1_-_153029980 | 2.99 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr8_+_120220561 | 2.98 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
chr14_+_69726656 | 2.97 |
ENST00000337827.4
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
chr10_+_24544249 | 2.97 |
ENST00000430453.2
|
KIAA1217
|
KIAA1217 |
chr20_-_44455976 | 2.96 |
ENST00000372555.3
|
TNNC2
|
troponin C type 2 (fast) |
chr3_-_46608010 | 2.96 |
ENST00000395905.3
|
LRRC2
|
leucine rich repeat containing 2 |
chr1_+_183155373 | 2.91 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
chr17_-_39780819 | 2.91 |
ENST00000311208.8
|
KRT17
|
keratin 17 |
chr12_+_48152774 | 2.87 |
ENST00000549243.1
|
SLC48A1
|
solute carrier family 48 (heme transporter), member 1 |
chr21_-_36421626 | 2.80 |
ENST00000300305.3
|
RUNX1
|
runt-related transcription factor 1 |
chr5_-_41794313 | 2.80 |
ENST00000512084.1
|
OXCT1
|
3-oxoacid CoA transferase 1 |
chr10_-_4285923 | 2.73 |
ENST00000418372.1
ENST00000608792.1 |
LINC00702
|
long intergenic non-protein coding RNA 702 |
chr19_-_35992780 | 2.68 |
ENST00000593342.1
ENST00000601650.1 ENST00000408915.2 |
DMKN
|
dermokine |
chr19_+_6740888 | 2.67 |
ENST00000596673.1
|
TRIP10
|
thyroid hormone receptor interactor 10 |
chr10_-_4285835 | 2.64 |
ENST00000454470.1
|
LINC00702
|
long intergenic non-protein coding RNA 702 |
chr1_-_158656488 | 2.61 |
ENST00000368147.4
|
SPTA1
|
spectrin, alpha, erythrocytic 1 (elliptocytosis 2) |
chr11_+_101983176 | 2.59 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr7_+_23286182 | 2.57 |
ENST00000258733.4
ENST00000381990.2 ENST00000409458.3 ENST00000539136.1 ENST00000453162.2 |
GPNMB
|
glycoprotein (transmembrane) nmb |
chr1_-_153066998 | 2.56 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
chr21_-_36421535 | 2.54 |
ENST00000416754.1
ENST00000437180.1 ENST00000455571.1 |
RUNX1
|
runt-related transcription factor 1 |
chr7_-_107643567 | 2.52 |
ENST00000393559.1
ENST00000439976.1 ENST00000393560.1 |
LAMB1
|
laminin, beta 1 |
chr11_+_393428 | 2.51 |
ENST00000533249.1
ENST00000527442.1 |
PKP3
|
plakophilin 3 |
chr6_+_47666275 | 2.49 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
chr1_+_152956549 | 2.49 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
chr20_+_34742650 | 2.49 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr14_+_69726864 | 2.48 |
ENST00000448469.3
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
chr13_+_78109884 | 2.47 |
ENST00000377246.3
ENST00000349847.3 |
SCEL
|
sciellin |
chr16_+_30077055 | 2.45 |
ENST00000564595.2
ENST00000569798.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr8_+_125860939 | 2.44 |
ENST00000525292.1
ENST00000528090.1 |
LINC00964
|
long intergenic non-protein coding RNA 964 |
chr18_+_55888767 | 2.43 |
ENST00000431212.2
ENST00000586268.1 ENST00000587190.1 |
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chrX_-_33229636 | 2.43 |
ENST00000357033.4
|
DMD
|
dystrophin |
chr16_+_58533951 | 2.42 |
ENST00000566192.1
ENST00000565088.1 ENST00000568640.1 ENST00000563978.1 ENST00000569923.1 ENST00000356752.4 ENST00000563799.1 ENST00000562999.1 ENST00000570248.1 ENST00000562731.1 ENST00000568424.1 |
NDRG4
|
NDRG family member 4 |
chr14_+_69726968 | 2.40 |
ENST00000553669.1
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
chr7_+_28448995 | 2.38 |
ENST00000424599.1
|
CREB5
|
cAMP responsive element binding protein 5 |
chr1_+_27719148 | 2.38 |
ENST00000374024.3
|
GPR3
|
G protein-coupled receptor 3 |
chr9_-_112179990 | 2.37 |
ENST00000394827.3
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3 |
chr17_-_9694614 | 2.35 |
ENST00000330255.5
ENST00000571134.1 |
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C |
chr12_+_10366223 | 2.35 |
ENST00000545290.1
|
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr6_-_4347271 | 2.34 |
ENST00000437430.2
|
RP3-527G5.1
|
RP3-527G5.1 |
chr1_+_156084461 | 2.31 |
ENST00000347559.2
ENST00000361308.4 ENST00000368300.4 ENST00000368299.3 |
LMNA
|
lamin A/C |
chr1_+_27189631 | 2.30 |
ENST00000339276.4
|
SFN
|
stratifin |
chr7_+_79998864 | 2.29 |
ENST00000435819.1
|
CD36
|
CD36 molecule (thrombospondin receptor) |
chr19_-_36004543 | 2.29 |
ENST00000339686.3
ENST00000447113.2 ENST00000440396.1 |
DMKN
|
dermokine |
chr1_-_153013588 | 2.28 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
chr12_+_10365082 | 2.27 |
ENST00000545859.1
|
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr19_+_39279838 | 2.26 |
ENST00000314980.4
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B |
chr2_+_36923830 | 2.24 |
ENST00000379242.3
ENST00000389975.3 |
VIT
|
vitrin |
chr11_-_102401469 | 2.22 |
ENST00000260227.4
|
MMP7
|
matrix metallopeptidase 7 (matrilysin, uterine) |
chr9_-_97356075 | 2.22 |
ENST00000375337.3
|
FBP2
|
fructose-1,6-bisphosphatase 2 |
chr16_+_30077098 | 2.22 |
ENST00000395240.3
ENST00000566846.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr12_+_10365404 | 2.21 |
ENST00000266458.5
ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chrX_-_15511438 | 2.21 |
ENST00000380420.5
|
PIR
|
pirin (iron-binding nuclear protein) |
chr12_-_48152853 | 2.19 |
ENST00000171000.4
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr3_+_174158732 | 2.17 |
ENST00000434257.1
|
NAALADL2
|
N-acetylated alpha-linked acidic dipeptidase-like 2 |
chr7_+_116312411 | 2.17 |
ENST00000456159.1
ENST00000397752.3 ENST00000318493.6 |
MET
|
met proto-oncogene |
chr7_-_107643674 | 2.15 |
ENST00000222399.6
|
LAMB1
|
laminin, beta 1 |
chr17_+_21191341 | 2.14 |
ENST00000526076.2
ENST00000361818.5 ENST00000316920.6 |
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr1_-_43751276 | 2.13 |
ENST00000423420.1
|
C1orf210
|
chromosome 1 open reading frame 210 |
chr17_-_53800217 | 2.13 |
ENST00000424486.2
|
TMEM100
|
transmembrane protein 100 |
chr6_-_46293378 | 2.13 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
chr13_-_36429763 | 2.12 |
ENST00000379893.1
|
DCLK1
|
doublecortin-like kinase 1 |
chr4_+_159727222 | 2.11 |
ENST00000512986.1
|
FNIP2
|
folliculin interacting protein 2 |
chr12_-_48152611 | 2.11 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr21_-_43786634 | 2.09 |
ENST00000291527.2
|
TFF1
|
trefoil factor 1 |
chr21_-_36421401 | 2.07 |
ENST00000486278.2
|
RUNX1
|
runt-related transcription factor 1 |
chr5_+_53751445 | 2.07 |
ENST00000302005.1
|
HSPB3
|
heat shock 27kDa protein 3 |
chr8_+_79503458 | 2.06 |
ENST00000518467.1
|
PKIA
|
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
chr13_+_53602894 | 2.05 |
ENST00000219022.2
|
OLFM4
|
olfactomedin 4 |
chr16_+_1306060 | 2.04 |
ENST00000397534.2
|
TPSD1
|
tryptase delta 1 |
chrX_-_74742846 | 2.04 |
ENST00000373361.3
|
ZDHHC15
|
zinc finger, DHHC-type containing 15 |
chr1_-_115880852 | 2.01 |
ENST00000369512.2
|
NGF
|
nerve growth factor (beta polypeptide) |
chr3_+_69928256 | 1.99 |
ENST00000394355.2
|
MITF
|
microphthalmia-associated transcription factor |
chr11_-_65667997 | 1.98 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
chr12_+_10366016 | 1.95 |
ENST00000546017.1
ENST00000535576.1 ENST00000539170.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr1_-_11918988 | 1.95 |
ENST00000376468.3
|
NPPB
|
natriuretic peptide B |
chr1_+_153003671 | 1.94 |
ENST00000307098.4
|
SPRR1B
|
small proline-rich protein 1B |
chr7_+_55177416 | 1.94 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
chr10_-_93392811 | 1.92 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
chr5_+_150020214 | 1.90 |
ENST00000307662.4
|
SYNPO
|
synaptopodin |
chr11_-_8739566 | 1.90 |
ENST00000533020.1
|
ST5
|
suppression of tumorigenicity 5 |
chr9_-_91793675 | 1.87 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
chr7_-_42276612 | 1.86 |
ENST00000395925.3
ENST00000437480.1 |
GLI3
|
GLI family zinc finger 3 |
chr4_+_169753156 | 1.86 |
ENST00000393726.3
ENST00000507735.1 |
PALLD
|
palladin, cytoskeletal associated protein |
chr3_-_149095652 | 1.85 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr16_+_2083265 | 1.85 |
ENST00000565855.1
ENST00000566198.1 |
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
chr1_+_150480551 | 1.84 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
chr13_+_102142296 | 1.83 |
ENST00000376162.3
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
chr2_+_220495800 | 1.83 |
ENST00000413743.1
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
chr12_-_56236711 | 1.82 |
ENST00000409200.3
|
MMP19
|
matrix metallopeptidase 19 |
chr1_+_198189921 | 1.82 |
ENST00000391974.3
|
NEK7
|
NIMA-related kinase 7 |
chr7_+_22766766 | 1.82 |
ENST00000426291.1
ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6
|
interleukin 6 (interferon, beta 2) |
chr1_-_209824643 | 1.82 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
chr11_-_8739383 | 1.80 |
ENST00000531060.1
|
ST5
|
suppression of tumorigenicity 5 |
chr16_+_1306093 | 1.80 |
ENST00000211076.3
|
TPSD1
|
tryptase delta 1 |
chr13_+_78109804 | 1.78 |
ENST00000535157.1
|
SCEL
|
sciellin |
chr5_-_149535190 | 1.78 |
ENST00000517488.1
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
chr6_+_74405501 | 1.77 |
ENST00000437994.2
ENST00000422508.2 |
CD109
|
CD109 molecule |
chr5_-_149535421 | 1.77 |
ENST00000261799.4
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
chr2_-_218766698 | 1.76 |
ENST00000439083.1
|
TNS1
|
tensin 1 |
chr1_+_39670360 | 1.75 |
ENST00000494012.1
|
MACF1
|
microtubule-actin crosslinking factor 1 |
chr12_+_110718921 | 1.75 |
ENST00000308664.6
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
chr3_+_156807663 | 1.73 |
ENST00000467995.1
ENST00000474477.1 ENST00000471719.1 |
LINC00881
|
long intergenic non-protein coding RNA 881 |
chr8_+_70476088 | 1.73 |
ENST00000525999.1
|
SULF1
|
sulfatase 1 |
chr3_+_155860751 | 1.72 |
ENST00000471742.1
|
KCNAB1
|
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
chr1_+_12042015 | 1.72 |
ENST00000412236.1
|
MFN2
|
mitofusin 2 |
chr5_+_140729649 | 1.72 |
ENST00000523390.1
|
PCDHGB1
|
protocadherin gamma subfamily B, 1 |
chr3_-_151034734 | 1.71 |
ENST00000260843.4
|
GPR87
|
G protein-coupled receptor 87 |
chr11_-_65667884 | 1.71 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chr3_-_73483055 | 1.71 |
ENST00000479530.1
|
PDZRN3
|
PDZ domain containing ring finger 3 |
chr19_-_46285736 | 1.70 |
ENST00000291270.4
ENST00000447742.2 ENST00000354227.5 |
DMPK
|
dystrophia myotonica-protein kinase |
chr1_-_12679171 | 1.69 |
ENST00000606790.1
|
RP11-474O21.5
|
RP11-474O21.5 |
chr7_-_135433534 | 1.67 |
ENST00000338588.3
|
FAM180A
|
family with sequence similarity 180, member A |
chr9_+_124329336 | 1.66 |
ENST00000394340.3
ENST00000436835.1 ENST00000259371.2 |
DAB2IP
|
DAB2 interacting protein |
chr1_-_6659876 | 1.65 |
ENST00000496707.1
|
KLHL21
|
kelch-like family member 21 |
chr10_+_121410882 | 1.65 |
ENST00000369085.3
|
BAG3
|
BCL2-associated athanogene 3 |
chr11_-_6341844 | 1.65 |
ENST00000303927.3
|
PRKCDBP
|
protein kinase C, delta binding protein |
chr1_+_150480576 | 1.64 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
chr8_-_72268721 | 1.64 |
ENST00000419131.1
ENST00000388743.2 |
EYA1
|
eyes absent homolog 1 (Drosophila) |
chr7_-_135433460 | 1.62 |
ENST00000415751.1
|
FAM180A
|
family with sequence similarity 180, member A |
chr11_-_6341724 | 1.61 |
ENST00000530979.1
|
PRKCDBP
|
protein kinase C, delta binding protein |
chr3_+_112930946 | 1.60 |
ENST00000462425.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
chr6_-_84140757 | 1.60 |
ENST00000541327.1
ENST00000369705.3 ENST00000543031.1 |
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chrX_+_99899180 | 1.59 |
ENST00000373004.3
|
SRPX2
|
sushi-repeat containing protein, X-linked 2 |
chr11_-_62457371 | 1.59 |
ENST00000317449.4
|
LRRN4CL
|
LRRN4 C-terminal like |
chr6_+_74405804 | 1.59 |
ENST00000287097.5
|
CD109
|
CD109 molecule |
chr6_+_125540951 | 1.58 |
ENST00000524679.1
|
TPD52L1
|
tumor protein D52-like 1 |
chr14_-_23624511 | 1.52 |
ENST00000529705.2
|
SLC7A8
|
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
chr11_-_62323702 | 1.52 |
ENST00000530285.1
|
AHNAK
|
AHNAK nucleoprotein |
chr1_+_156096336 | 1.52 |
ENST00000504687.1
ENST00000473598.2 |
LMNA
|
lamin A/C |
chr1_+_152881014 | 1.51 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
chr11_+_57531292 | 1.50 |
ENST00000524579.1
|
CTNND1
|
catenin (cadherin-associated protein), delta 1 |
chr3_+_112930387 | 1.48 |
ENST00000485230.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
chr10_+_17270214 | 1.45 |
ENST00000544301.1
|
VIM
|
vimentin |
chr18_+_21452804 | 1.44 |
ENST00000269217.6
|
LAMA3
|
laminin, alpha 3 |
chr2_-_65593784 | 1.44 |
ENST00000443619.2
|
SPRED2
|
sprouty-related, EVH1 domain containing 2 |
chr2_+_68872954 | 1.44 |
ENST00000394342.2
|
PROKR1
|
prokineticin receptor 1 |
chr4_+_159727272 | 1.43 |
ENST00000379346.3
|
FNIP2
|
folliculin interacting protein 2 |
chr11_-_71781096 | 1.42 |
ENST00000535087.1
ENST00000535838.1 |
NUMA1
|
nuclear mitotic apparatus protein 1 |
chr19_-_35981358 | 1.42 |
ENST00000484218.2
ENST00000338897.3 |
KRTDAP
|
keratinocyte differentiation-associated protein |
chr11_+_34643600 | 1.42 |
ENST00000530286.1
ENST00000533754.1 |
EHF
|
ets homologous factor |
chr3_+_167584414 | 1.42 |
ENST00000475324.1
|
RP11-298O21.2
|
RP11-298O21.2 |
chr12_-_53297432 | 1.41 |
ENST00000546900.1
|
KRT8
|
keratin 8 |
chr3_-_194090460 | 1.40 |
ENST00000428839.1
ENST00000347624.3 |
LRRC15
|
leucine rich repeat containing 15 |
chr8_+_22844995 | 1.40 |
ENST00000524077.1
|
RHOBTB2
|
Rho-related BTB domain containing 2 |
chr12_-_56236690 | 1.40 |
ENST00000322569.4
|
MMP19
|
matrix metallopeptidase 19 |
chr18_+_31185530 | 1.39 |
ENST00000586327.1
|
ASXL3
|
additional sex combs like 3 (Drosophila) |
chr2_+_47596287 | 1.38 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
chr6_-_56819385 | 1.36 |
ENST00000370754.5
ENST00000449297.2 |
DST
|
dystonin |
chr18_+_21452964 | 1.36 |
ENST00000587184.1
|
LAMA3
|
laminin, alpha 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.7 | 16.8 | GO:0002159 | desmosome assembly(GO:0002159) |
1.2 | 3.6 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
1.2 | 3.5 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
1.0 | 6.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.9 | 4.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.9 | 4.5 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.9 | 4.3 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.8 | 2.5 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
0.8 | 12.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.8 | 2.5 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.8 | 11.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 5.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.7 | 5.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.6 | 1.9 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 2.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.6 | 2.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.5 | 2.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.5 | 1.9 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.5 | 16.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.5 | 3.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 1.8 | GO:0002384 | hepatic immune response(GO:0002384) response to prolactin(GO:1990637) |
0.4 | 4.4 | GO:0001554 | luteolysis(GO:0001554) |
0.4 | 10.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 3.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 7.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 8.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 11.0 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.4 | 0.7 | GO:1903524 | positive regulation of vasoconstriction(GO:0045907) positive regulation of blood circulation(GO:1903524) |
0.4 | 2.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 0.7 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.4 | 1.1 | GO:0003099 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.3 | 2.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.3 | 1.4 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.3 | 6.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 12.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 4.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 1.0 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.3 | 3.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.3 | 2.3 | GO:1903281 | protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.3 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 0.9 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.3 | 5.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 1.2 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.3 | 6.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 1.5 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 4.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 5.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.3 | 1.1 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.3 | 7.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 2.1 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.2 | 0.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 1.0 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 1.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 5.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 1.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.7 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.2 | 2.4 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.2 | 0.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 3.0 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 2.3 | GO:2000334 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.2 | 2.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 2.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.2 | 3.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 3.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 1.2 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.2 | 2.6 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 7.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 1.7 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.2 | 12.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.5 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.2 | 1.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 2.9 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 3.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.8 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.2 | 2.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 4.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 1.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 0.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 1.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 5.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.8 | GO:0030421 | defecation(GO:0030421) |
0.1 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.6 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.1 | 1.4 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.9 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 2.5 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 2.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.6 | GO:0044650 | adhesion of symbiont to host cell(GO:0044650) |
0.1 | 0.8 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 3.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.9 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 11.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 1.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 3.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.3 | GO:0031394 | maternal aggressive behavior(GO:0002125) positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 1.2 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 2.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 1.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 2.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.1 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 2.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 1.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.1 | 0.9 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 1.8 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 1.7 | GO:0060539 | diaphragm development(GO:0060539) negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.1 | 0.8 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 3.5 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.1 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.9 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 0.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 2.8 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.3 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.1 | 0.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 2.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.6 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 1.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 1.1 | GO:0051964 | netrin-activated signaling pathway(GO:0038007) negative regulation of synapse assembly(GO:0051964) |
0.1 | 1.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.3 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.1 | 3.9 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.1 | 0.5 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.1 | 2.4 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 1.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 2.9 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 1.7 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 0.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.1 | 1.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 2.0 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.9 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 2.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 3.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 2.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 2.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 9.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.0 | 0.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.0 | 0.8 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) axon midline choice point recognition(GO:0016199) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 2.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 2.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 1.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 3.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 1.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.5 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 1.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 3.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.4 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.0 | 1.1 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.8 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.1 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.0 | 1.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.5 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 2.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.1 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.0 | 0.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.8 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.0 | 0.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 1.6 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 1.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 1.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 1.8 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.4 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 3.0 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 2.5 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 4.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 1.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 1.6 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.0 | 0.1 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 2.3 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 4.0 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.1 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 1.2 | GO:0051785 | positive regulation of mitotic nuclear division(GO:0045840) positive regulation of nuclear division(GO:0051785) |
0.0 | 0.4 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.0 | 0.3 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 1.1 | GO:0009798 | axis specification(GO:0009798) |
0.0 | 0.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 1.8 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 1.0 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 4.5 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 2.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 1.4 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
0.0 | 0.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.0 | 1.6 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.3 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.4 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:0097444 | spine apparatus(GO:0097444) |
1.9 | 7.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.2 | 3.6 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.8 | 4.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.7 | 10.7 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.6 | 1.9 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.6 | 10.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 1.7 | GO:1990032 | parallel fiber(GO:1990032) |
0.5 | 18.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 6.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.5 | 2.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 2.0 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.4 | 4.5 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 15.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 1.3 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.4 | 4.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 5.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 3.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 13.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 0.6 | GO:0044753 | amphisome(GO:0044753) |
0.3 | 2.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 10.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 17.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 2.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.4 | GO:0031673 | H zone(GO:0031673) |
0.2 | 3.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 7.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 0.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 2.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 3.0 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 1.4 | GO:0055028 | cortical microtubule(GO:0055028) |
0.1 | 1.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 5.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 2.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 4.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 4.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 33.1 | GO:0031674 | I band(GO:0031674) |
0.1 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 3.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 2.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 2.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.5 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 12.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 2.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 1.2 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 0.4 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 3.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 2.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 1.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 2.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.8 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.0 | 0.9 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 3.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 3.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 2.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 3.9 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 6.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 3.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 2.1 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 3.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 2.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 1.3 | GO:0005844 | polysome(GO:0005844) |
0.0 | 1.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 2.5 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.8 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.0 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 3.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 1.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 6.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 1.1 | GO:0043234 | protein complex(GO:0043234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 5.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.2 | 3.6 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
1.2 | 3.6 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
1.1 | 9.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.9 | 3.5 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.8 | 2.5 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
0.8 | 4.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.7 | 5.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 15.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 2.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.6 | 2.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.6 | 2.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.5 | 3.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 8.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 6.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.4 | 4.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 1.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 3.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 1.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.4 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.3 | 5.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 2.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.3 | 1.0 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.3 | 2.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 6.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 1.1 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) sulfonylurea receptor binding(GO:0017098) pyrimidine ribonucleoside binding(GO:0032551) |
0.3 | 7.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 2.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 9.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.2 | 4.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 1.6 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.2 | 3.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 2.3 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.2 | 0.6 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.2 | 4.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 5.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 2.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 6.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 3.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 3.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 1.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 2.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.8 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.2 | 1.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 3.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.8 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.2 | 1.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 5.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.4 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.1 | 0.9 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 10.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 1.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 3.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.5 | GO:1990175 | EH domain binding(GO:1990175) |
0.1 | 1.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.3 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 10.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.5 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 2.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 1.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 2.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 4.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 2.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.4 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 0.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 0.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.5 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 2.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 2.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 12.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 4.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 1.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 2.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 2.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 2.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 1.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 1.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 1.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 2.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 8.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 1.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 1.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 2.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 3.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 49.8 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 4.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 2.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 1.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 1.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 5.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.8 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 9.4 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 1.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 11.9 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 2.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 3.7 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 3.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 13.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 18.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 7.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 18.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 9.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 8.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 4.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 4.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 10.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 4.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 5.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 2.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 2.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 6.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 3.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 2.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 3.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 3.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 2.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 2.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 13.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 2.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 2.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 5.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 1.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.2 | PID E2F PATHWAY | E2F transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 10.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 3.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 3.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 1.5 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.2 | 7.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 9.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 10.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 5.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 5.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 6.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 6.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 4.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 8.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 5.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 4.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 10.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 2.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 6.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 3.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 5.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 2.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 1.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 2.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 1.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 2.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 1.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 1.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 8.4 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 2.9 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 1.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |